Cargando…
In vivo characterization of a doxorubicin resistant B16 melanoma cell line.
A doxorubicin-resistant line of B16 melanoma (B16VDXR) was obtained in vitro by continuous exposure to increasing concentrations of doxorubicin of an in vitro line (B16V) derived from the in vivo transplanted B16 melanoma. When injected s.c. into mice, B16VDXR exhibited histological features, metast...
Autores principales: | Formelli, F., Rossi, C., Supino, R., Parmiani, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001516/ https://www.ncbi.nlm.nih.gov/pubmed/3741758 |
Ejemplares similares
-
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.
por: Supino, R., et al.
Publicado: (1986) -
Verapamil potentiation of doxorubicin resistance development in B16 melanoma cells both in vitro and in vivo.
por: Formelli, F., et al.
Publicado: (1988) -
Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.
por: Supino, R., et al.
Publicado: (1988) -
P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines.
por: Capranico, G., et al.
Publicado: (1989) -
In Vitro and in Vivo Anticancer Activity of Aconitine on Melanoma Cell Line B16
por: Du, Juan, et al.
Publicado: (2013)